These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12387700)

  • 21. Cannabinoids: novel medicines for the treatment of Huntington's disease.
    Sagredo O; Pazos MR; Valdeolivas S; Fernandez-Ruiz J
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):41-8. PubMed ID: 22280340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation.
    Correa F; Mestre L; Molina-Holgado E; Arévalo-Martín A; Docagne F; Romero E; Molina-Holgado F; Borrell J; Guaza C
    Mini Rev Med Chem; 2005 Jul; 5(7):671-5. PubMed ID: 16026313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of cannabinoid-based drugs.
    Klein TW; Newton CA
    Adv Exp Med Biol; 2007; 601():395-413. PubMed ID: 17713029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression.
    Mechoulam R
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):93-9. PubMed ID: 12052029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective agents: cannabinoids.
    Sánchez AJ; García-Merino A
    Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid-based medicines for neurological disorders--clinical evidence.
    Wright S
    Mol Neurobiol; 2007 Aug; 36(1):129-36. PubMed ID: 17952657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
    Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
    Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid receptors and their role in neuroprotection.
    van der Stelt M; Di Marzo V
    Neuromolecular Med; 2005; 7(1-2):37-50. PubMed ID: 16052037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.
    Fernández-Ruiz J; Moro MA; Martínez-Orgado J
    Neurotherapeutics; 2015 Oct; 12(4):793-806. PubMed ID: 26260390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids: new promising agents in the treatment of neurological diseases.
    Giacoppo S; Mandolino G; Galuppo M; Bramanti P; Mazzon E
    Molecules; 2014 Nov; 19(11):18781-816. PubMed ID: 25407719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endocannabinoid system as a target for the treatment of neuronal damage.
    Fernández-Ruiz J; García C; Sagredo O; Gómez-Ruiz M; de Lago E
    Expert Opin Ther Targets; 2010 Apr; 14(4):387-404. PubMed ID: 20230193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic potential of cannabis.
    Baker D; Pryce G; Giovannoni G; Thompson AJ
    Lancet Neurol; 2003 May; 2(5):291-8. PubMed ID: 12849183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis: old medicine with new promise for neurological disorders.
    Carter GT; Weydt P
    Curr Opin Investig Drugs; 2002 Mar; 3(3):437-40. PubMed ID: 12054093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds.
    Lins BR; Anyaegbu CC; Hellewell SC; Papini M; McGonigle T; De Prato L; Shales M; Fitzgerald M
    J Neuroinflammation; 2023 Mar; 20(1):77. PubMed ID: 36935484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders.
    Friedman D; French JA; Maccarrone M
    Lancet Neurol; 2019 May; 18(5):504-512. PubMed ID: 30910443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.
    Antonazzo M; Botta M; Bengoetxea H; Ruiz-Ortega JÁ; Morera-Herreras T
    Int Rev Neurobiol; 2019; 146():229-257. PubMed ID: 31349929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.
    Latorre JG; Schmidt EB
    Curr Cardiol Rep; 2015 Sep; 17(9):627. PubMed ID: 26238742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases.
    Sharon N; Yarmolinsky L; Khalfin B; Fleisher-Berkovich S; Ben-Shabat S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.